Bioreductive prodrugs for cancer therapy.

Methods in molecular medicine

Volumn 90, Issue , 2004, Pages 515-542

  Seddon, Beatrice ^a   Kelland, Lloyd R ^a   Workman, Paul ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PRODRUG;

ANIMAL; BIOTRANSFORMATION; CELL HYPOXIA; CLINICAL TRIAL; DRUG EFFECT; GENE THERAPY; HUMAN; METHODOLOGY; NEOPLASM; OXIDATION REDUCTION REACTION; PATHOLOGY; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOTRANSFORMATION; CELL HYPOXIA; CLINICAL TRIALS; GENE THERAPY; HUMANS; NEOPLASMS; OXIDATION-REDUCTION; PRODRUGS;

EID: 1542676973     PISSN: 15431894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (167)